Abstract Details

Title A Relative Bioavailability Study of Three Dose Strengths and Four Dose Levels of SD-809, a Potential Treatment for Movement Disorders

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 054

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David A. Stamler, MD (Alterity Therapeutics) PRESENTER	Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
	No disclosure on file
Lisa De Boer	No disclosure on file
	No disclosure on file

��ɫ��